• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多脂质指标轨迹与早发性心血管疾病的关系:一项队列研究。

Association of Multitrajectories of Lipid Indices With Premature Cardiovascular Disease: A Cohort Study.

机构信息

Department of Neurology Beijing Tiantan Hospital, Capital Medical University Beijing China.

China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital Capital Medical University Beijing China.

出版信息

J Am Heart Assoc. 2023 May 2;12(9):e029173. doi: 10.1161/JAHA.122.029173. Epub 2023 Apr 29.

DOI:10.1161/JAHA.122.029173
PMID:37119078
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10227234/
Abstract

Background The multitrajectory model can identify joint longitudinal patterns of different lipids simultaneously, which might help better understand the heterogeneous risk of premature cardiovascular disease (CVD) and facilitate targeted prevention programs. This study aimed to investigate the associations between multitrajectories of lipids with premature CVD. Methods and Results The study enrolled 78 526 participants from the Kailuan study, a prospective cohort study in Tangshan, China. Five distinct multitrajectories of triglyceride, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol over 6-year exposure were identified on the basis of Nagin's criteria, using group-based multitrajectory modeling. During a median follow-up of 6.75 years (507 645.94 person-years), 665 (0.85%) premature CVDs occurred. After adjustment for confounders, the highest risk of premature CVD was observed in group 4 (the highest and increasing triglyceride, optimal and decreasing LDL-C, low and decreasing high-density lipoprotein cholesterol) (hazard ratio [HR], 2.13 [95% CI, 1.36-3.32]), followed by group 5 (high and decreasing triglyceride, optimal and increasing LDL-C, low and decreasing high-density lipoprotein cholesterol) (HR, 2.07 [95% CI, 1.45-2.98]), and group 3 (optimal and increasing triglyceride, borderline high and increasing LDL-C, optimal and decreasing high-density lipoprotein cholesterol) (HR, 1.90 [95% CI, 1.32-2.73]). Conclusions Our results showed that the residual risk of premature CVD caused by increasing triglyceride levels remained high despite the fact that LDL-C levels were optimal or declining over time. These findings emphasized the importance of assessing the joint longitudinal patterns of lipids and undertaking potential interventions on triglyceride lowering to reduce the residual risk of premature CVD, even among individuals with optimal LDL-C levels.

摘要

背景

多轨迹模型可以同时识别不同脂质的联合纵向模式,这可能有助于更好地了解过早发生心血管疾病(CVD)的异质风险,并促进有针对性的预防计划。本研究旨在探讨脂质多轨迹与过早 CVD 的相关性。

方法和结果

本研究纳入了来自中国唐山的一项前瞻性队列研究——开滦研究的 78526 名参与者。基于 Nagin 的标准,使用基于群组的多轨迹建模,在 6 年的暴露时间内确定了甘油三酯、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇的 5 种不同的多轨迹。在中位数为 6.75 年(507645.94 人年)的随访期间,发生了 665 例(0.85%)过早 CVD。在校正混杂因素后,观察到第 4 组(甘油三酯最高且逐渐升高,LDL-C 最佳且逐渐降低,高密度脂蛋白胆固醇最低且逐渐降低)发生过早 CVD 的风险最高(危险比[HR],2.13[95%CI,1.36-3.32]),其次是第 5 组(甘油三酯高且逐渐降低,LDL-C 最佳且逐渐升高,高密度脂蛋白胆固醇最低且逐渐降低)(HR,2.07[95%CI,1.45-2.98]),和第 3 组(甘油三酯最佳且逐渐升高,边缘高且 LDL-C 逐渐升高,高密度脂蛋白胆固醇最佳且逐渐降低)(HR,1.90[95%CI,1.32-2.73])。

结论

我们的研究结果表明,尽管 LDL-C 水平随着时间的推移而保持最佳或下降,但升高的甘油三酯水平导致过早发生 CVD 的残余风险仍然很高。这些发现强调了评估脂质联合纵向模式的重要性,并采取潜在的干预措施降低甘油三酯,以降低即使在 LDL-C 水平最佳的个体中过早发生 CVD 的残余风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0570/10227234/9f42e92a955b/JAH3-12-e029173-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0570/10227234/86569e341bda/JAH3-12-e029173-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0570/10227234/76813c4fe08f/JAH3-12-e029173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0570/10227234/dd181b0a8354/JAH3-12-e029173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0570/10227234/9f42e92a955b/JAH3-12-e029173-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0570/10227234/86569e341bda/JAH3-12-e029173-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0570/10227234/76813c4fe08f/JAH3-12-e029173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0570/10227234/dd181b0a8354/JAH3-12-e029173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0570/10227234/9f42e92a955b/JAH3-12-e029173-g004.jpg

相似文献

1
Association of Multitrajectories of Lipid Indices With Premature Cardiovascular Disease: A Cohort Study.多脂质指标轨迹与早发性心血管疾病的关系:一项队列研究。
J Am Heart Assoc. 2023 May 2;12(9):e029173. doi: 10.1161/JAHA.122.029173. Epub 2023 Apr 29.
2
Multi-trajectories of lipid indices with incident cardiovascular disease, heart failure, and all-cause mortality: 23 years follow-up of two US cohort studies.脂质指标与心血管疾病、心力衰竭和全因死亡率的多轨迹关系:两项美国队列研究 23 年随访。
J Transl Med. 2021 Jul 3;19(1):286. doi: 10.1186/s12967-021-02966-4.
3
Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol.残余动脉粥样硬化性心血管疾病风险:关注非高密度脂蛋白胆固醇
J Cardiovasc Pharmacol Ther. 2023 Jan-Dec;28:10742484231189597. doi: 10.1177/10742484231189597.
4
On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).接受强效他汀类药物治疗后,治疗中检测的非高密度脂蛋白胆固醇、载脂蛋白 B、甘油三酯和血脂比值与残余血管风险的关系:JUPITER(他汀类药物预防作用的验证:一项评价瑞舒伐他汀的干预试验)。
J Am Coll Cardiol. 2012 Apr 24;59(17):1521-8. doi: 10.1016/j.jacc.2011.12.035.
5
Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.美国接受他汀类药物治疗成年人中根据低密度脂蛋白胆固醇、非高密度脂蛋白胆固醇和载脂蛋白B划分的残余血脂异常:2009 - 2010年美国国家健康和营养检查调查
J Clin Lipidol. 2015 Jul-Aug;9(4):525-32. doi: 10.1016/j.jacl.2015.05.003. Epub 2015 May 16.
6
Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.在 10 年发生动脉粥样硬化性心血管疾病风险低的个体中,低密度脂蛋白胆固醇与心血管死亡率的长期关联。
Circulation. 2018 Nov 20;138(21):2315-2325. doi: 10.1161/CIRCULATIONAHA.118.034273.
7
Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012).按体重状况、饮食习惯和降脂治疗划分的 LDL-C、HDL-C、lp(a) 和 TG 水平对心血管疾病发病的长期预后价值:ATTICA 流行病学队列研究(2002-2012 年)。
Lipids Health Dis. 2022 Dec 19;21(1):141. doi: 10.1186/s12944-022-01747-2.
8
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.在管理式医疗环境中,以低高密度脂蛋白胆固醇为靶点降低残余心血管风险。
J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1.
9
Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study.中国 2 型糖尿病患者心血管事件预防的血脂控制和调脂药物使用:一项前瞻性队列研究。
Cardiovasc Diabetol. 2010 Nov 22;9:77. doi: 10.1186/1475-2840-9-77.
10
Impact of hypertriglyceridaemia on cardiovascular mortality according to low-density lipoprotein cholesterol in a 15.6-million population.根据 1560 万人群的低密度脂蛋白胆固醇水平,探讨高甘油三酯血症对心血管死亡率的影响。
Eur J Prev Cardiol. 2024 Feb 15;31(3):280-290. doi: 10.1093/eurjpc/zwad330.

引用本文的文献

1
Novel Insights into Causal Effects of Serum Lipids and Apolipoproteins on Cardiovascular Morpho-Functional Phenotypes.血清脂质和载脂蛋白对心血管形态-功能表型因果关系的新见解。
Cardiovasc Toxicol. 2024 Dec;24(12):1364-1379. doi: 10.1007/s12012-024-09930-w. Epub 2024 Oct 11.
2
Associations between the Serum Triglyceride Level and Kidney Outcome in Patients with Chronic Kidney Disease: The Fukuoka Kidney disease Registry Study.血清甘油三酯水平与慢性肾脏病患者肾脏结局的关系:福冈肾脏病登记研究。
J Atheroscler Thromb. 2024 Nov 1;31(11):1556-1570. doi: 10.5551/jat.64625. Epub 2024 May 11.
3
Multi-trajectories of triglyceride-glucose index and lifestyle with Cardiovascular Disease: a cohort study.

本文引用的文献

1
U-Shaped Relationship of High-Density Lipoprotein Cholesterol and Incidence of Total, Ischemic and Hemorrhagic Stroke: A Prospective Cohort Study.高密度脂蛋白胆固醇与总卒中、缺血性卒中和出血性卒中发生率的U型关系:一项前瞻性队列研究
Stroke. 2022 May;53(5):1624-1632. doi: 10.1161/STROKEAHA.121.034393. Epub 2022 Jan 28.
2
Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events.青年期和中年时期累积低密度脂蛋白胆固醇暴露与心血管事件风险的关系。
JAMA Cardiol. 2021 Dec 1;6(12):1406-1413. doi: 10.1001/jamacardio.2021.3508.
3
Multi-trajectories of lipid indices with incident cardiovascular disease, heart failure, and all-cause mortality: 23 years follow-up of two US cohort studies.
甘油三酯-葡萄糖指数与生活方式的多轨迹与心血管疾病:一项队列研究。
Cardiovasc Diabetol. 2023 Dec 13;22(1):341. doi: 10.1186/s12933-023-02076-z.
4
Remnant Cholesterol in Young Adulthood Is Associated With Left Ventricular Remodeling and Dysfunction in Middle Age: The CARDIA Study.青年时期残留胆固醇与中年左心室重构和功能障碍有关:CARDIA 研究。
Circ Cardiovasc Imaging. 2023 Nov;16(11):e015589. doi: 10.1161/CIRCIMAGING.123.015589. Epub 2023 Nov 21.
脂质指标与心血管疾病、心力衰竭和全因死亡率的多轨迹关系:两项美国队列研究 23 年随访。
J Transl Med. 2021 Jul 3;19(1):286. doi: 10.1186/s12967-021-02966-4.
4
Cumulative burden of lipid profiles predict future incidence of ischaemic stroke and residual risk.血脂谱的累积负担可预测未来缺血性卒中的发生和残余风险。
Stroke Vasc Neurol. 2021 Dec;6(4):581-588. doi: 10.1136/svn-2020-000726. Epub 2021 Apr 7.
5
Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.残胆固醇而非 LDL 胆固醇与心血管疾病事件相关。
J Am Coll Cardiol. 2020 Dec 8;76(23):2712-2724. doi: 10.1016/j.jacc.2020.10.008.
6
The association between triglycerides and incident cardiovascular disease: What is "optimal"?甘油三酯与心血管事件的相关性:“最佳”水平是多少?
J Clin Lipidol. 2020 Jul-Aug;14(4):438-447.e3. doi: 10.1016/j.jacl.2020.04.009. Epub 2020 May 6.
7
Association of Age of Onset of Hypertension With Cardiovascular Diseases and Mortality.高血压发病年龄与心血管疾病及死亡率的关系。
J Am Coll Cardiol. 2020 Jun 16;75(23):2921-2930. doi: 10.1016/j.jacc.2020.04.038.
8
Association of changes in lipids with risk of myocardial infarction among people without lipid-lowering therapy.降脂治疗人群中血脂变化与心肌梗死风险的相关性研究。
Atherosclerosis. 2020 May;301:69-78. doi: 10.1016/j.atherosclerosis.2020.03.026. Epub 2020 Apr 2.
9
Visit-to-Visit Variability of Lipids Measurements and the Risk of Stroke and Stroke Types: A Prospective Cohort Study.血脂测量的就诊间变异性与中风风险及中风类型:一项前瞻性队列研究。
J Stroke. 2020 Jan;22(1):119-129. doi: 10.5853/jos.2019.02075. Epub 2020 Jan 31.
10
Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies.动脉粥样硬化性心血管疾病患者中高甘油三酯血症与心血管结局的真实世界风险以及新兴疗法的潜在适用性
Eur Heart J. 2020 Jan 1;41(1):86-94. doi: 10.1093/eurheartj/ehz767.